Clinical Trials
All Clinical Trials - Page 70 of 75
A complete, crawlable index of every tracked clinical trial of peptide compounds. Use the search browser at /trials for filtering, or page through the full list here.
- NCT00800930Phase 2Completed
Therapeutic Induction of Endogenous Antibiotics
Ll-37
- NCT00154414Phase 2Completed
Effect of Liraglutide on Blood Glucose Control in Japanese Subjects With Type 2 Diabetes
Liraglutide
- NCT00154401Phase 2Completed
Effect of Liraglutide on Blood Glucose Control in Subjects With Type 2 Diabetes
Liraglutide
- NCT00517283Phase 1Completed
A Study by Scintigraphy to Evaluate the Effect of Exenatide on Gastric Emptying in Subjects With Type 2 Diabetes
Exenatide
- NCT00489645N/ACompleted
Effect of Hyperglycemia on Gastric Emptying Interactions With Pramlintide
Pramlintide
- NCT00444873Phase 3Completed
Effect of 120mg Somatuline Autogel at Different Dose Intervals (28, 42 or 56 Days) in Patients With Acromegaly
Lanreotide
- NCT00113360Phase 2Completed
RAD001 Plus Octreotide Depot in Metastatic or Unresectable Low Grade Neuroendocrine Carcinoma
Octreotide
- NCT01029275N/ACompleted
Somatostatin Analog Treatment of Acromegaly Before Pituitary Surgery : Comparison With Neurosurgery Alone
Octreotide
- NCT00635310N/AUnknown
Safety Profiles of Liver Biopsy in Hemodialysis Patients With Chronic Viral Hepatitis Pre-treated With Vasopressin
Desmopressin
- NCT01178996Phase 3Completed
Thymosin Alpha-1 in Combination With Peg-Interferon Alfa- 2a and Ribavirin for the Therapy of Chronic Hepatitis C Nonresponsive to the Combination of IFN and Ribavirin.
Thymosin-Alpha-1
- NCT00190944Phase 2Completed
Effects of Teriparatide on Distal Radius Fracture Healing
Teriparatide
- NCT00209261Phase 4Completed
A 6-week Open Label Cross-over Study With 2 Different Daily Doses of Minirin® Oral Lyophilisate in Children and Adolescents With Primary Nocturnal Enuresis (PNE)
Desmopressin
- NCT00566813Phase 1/Phase 2Completed
Islet Transplantation in Type 1 Diabetic Patients Using the Edmonton Protocol of Steroid Free Immunosuppression
Exenatide
- NCT01155232N/AActive Not Recruiting
Effects of Teriparatide (PTH) on Bone in Men and Women With Osteoporosis
Teriparatide
- NCT00079924Phase 4Completed
Effects of Teriparatide in Postmenopausal Women With Osteoporosis
Teriparatide
- NCT00590343Phase 2Completed
Safety and Efficacy Study of PTK787/ZK222584 to Treat Metastatic Neuroendocrine Tumors
Octreotide
- NCT00104715Phase 3Completed
Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer
Gonadorelin
- NCT00293696Phase 4Completed
Casodex/Zoladex Biomarkers in Localised Prostate Cancer
Gonadorelin
- NCT00197860Phase 1/Phase 2Completed
Dendritic Cell Based Therapy of Renal Cell Carcinoma
Thymosin-Alpha-1
- NCT00097500Phase 3Completed
Effects of Exenatide and Insulin Glargine in Subjects With Type 2 Diabetes
Exenatide
- NCT01077323N/ACompleted
A Retrospective Cohort Study of Acute Pancreatitis in Relation to Use of Exenatide and Other Antidiabetic Agents
Exenatide
- NCT00099619Phase 3Completed
Comparing Exenatide and Insulin Glargine in Type 2 Diabetes Patients for Whom Insulin is the Next Appropriate Therapy
Exenatide
- NCT00171730Phase 2Completed
An Extension Study to Assess the Long-Term Safety and Efficacy of Pasireotide in Participants With Acromegaly
Octreotide
- NCT00427245Phase 3Completed
Goserelin in Preventing Early Menopause in Premenopausal Women Undergoing Chemotherapy for Stage I, Stage II, or Stage III Breast Cancer
Gonadorelin
- NCT00458458Phase 3Unknown
Treatment of Endometriosis With Norethindrone Acetate ( NA) VS. Gonadotropin- Releasing Hormone (GnRH) Agonist (Lupron Depot 11.25 mg)
Gonadorelin
- NCT00349258Phase 4Completed
The Use of GnRH Agonist Trigger in the Prevention of OHSS
Gonadorelin
- NCT00444561Phase 2Completed
Exploratory Study to Evaluate Various Pharmacodynamic Effects of Subcutaneously Infused or Injected Pramlintide in Obese Subjects
Pramlintide
- NCT00074711Phase 2Completed
Adding Phosphorus to Osteoporosis Drug Treatment
Teriparatide
- NCT00277706Phase 1Completed
Impact of Parathyroid Hormone (PTH) on Osseous Cavity
Teriparatide
- NCT00175305Phase 3Terminated
Prader-Willi Syndrome and Appetite
Octreotide
- NCT01069094Phase 1/Phase 2Completed
A Study of Progenta (CDB-4124) in Pre-menopausal Women With Symptomatic Leiomyomata
Gonadorelin
- NCT00081159Phase 2Completed
Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases
Gonadorelin
- NCT00090844Phase 2Terminated
Triptorelin for Preserving Ovarian Function in Premenopausal Women Receiving Chemotherapy for Early-Stage Breast Cancer
Gonadorelin
- NCT00191321Phase 3Completed
Teriparatide Use in Hip Replaced Subjects
Teriparatide
- NCT00092287Phase 3Terminated
Comparison of Lanreotide Autogel® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid Syndrome
Octreotide
- NCT00230594Phase 3Completed
Desmopressin Response in the Young
Desmopressin
- NCT00216398Phase 4Completed
Lanreotide Autogel in Patients With Acromegaly Previously Treated With Octreotide LAR
Octreotide
- NCT01508897Phase 1Completed
Comparison of Two Liraglutide Formulations in Healthy Volunteers
Liraglutide
- NCT00081458Phase 3Completed
Safety and Efficacy Study of Teduglutide in Subjects With Short Bowel Syndrome
Teduglutide
- NCT00175396Phase 3Unknown
Androgen Suppression Combined With Elective Nodal and Dose Escalated Radiation Therapy
Gonadorelin
- NCT00099320Phase 3Completed
Safety and Efficacy of Exenatide in Patients With Type 2 Diabetes Using Thiazolidinediones or Thiazolidinediones and Metformin
Exenatide
- NCT00473265Phase 2/Phase 3Completed
Bone Properties in Hypoparathyroidism: Effects of PTH
Teriparatide
- NCT00086619Phase 2Completed
Parathyroid Hormone (PTH) for Osteoporosis in Postmenopausal Women
Teriparatide
- NCT00534677Phase 4Completed
The Safety & Efficacy of Terlipressin vs Octreotide for the Control of Variceal Bleed
Octreotide
- NCT01011751Phase 3Completed
Treatment of Hot Flushes Caused by Leuprorelin 11.25 mg in Prostate Adenocarcinoma
Gonadorelin
- NCT01507337Phase 1Completed
Comparison of the Effect of Liraglutide in Young Versus Elderly Healthy Volunteers
Liraglutide
- NCT01371643Phase 4Completed
Surgical Debulking of Pituitary Adenomas
Octreotide
- NCT00902655Phase 4Completed
Desmopressin in the Treatment of Mixed Nocturia With Nocturnal Polyuria and Low Nocturnal Bladder Capacity
Desmopressin
- NCT00308438Phase 2Completed
Safety and Efficacy of ALX-0600 in Subjects With Active Crohn's Disease Who Completed Protocol CL0600-008
Teduglutide
- NCT00791843Phase 2Completed
The Effect of GHRH Therapy on Myocardial Structure and Function in Congestive Heart Failure
Sermorelin